European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trumps latest tariff barrage.
Wary European Drugmakers Think They Can Avoid Trumps Latest Tariffs
The New York Times - 26 Sep 2025 13:57
European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trumps latest tariff barrage.
Share this Article
Recommended